IRadimed Corp (NASDAQ:IRMD)
| 31.55 Delayed Data As of May 20 |  +0.21 / +0.67%Today’s Change | 27.08 Today|||52-Week Range 55.92 | -31.72% Year-to-Date |
Latest IRMD News | Press Releases
| After Plunging 27.4% in 4 Weeks, Here's Why the Trend Might Reverse for iRadimed (IRMD) May 10 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 31.34 |
| Today’s open | 31.13 |
| Day’s range | 30.93 - 31.61 |
| Volume | 1,223 |
| Average volume (3 months) | 88,829 |
| Market cap | $396.4M |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | +569.00% |
| Earnings growth (this year) | +21.69% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +31.83% |
| P/E ratio | 38.0 |
| Price/Sales | 13.91 |
| Price/Book | 5.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AXGNAxoGen Inc | +0.46 | +4.83% |
| ZYXIZynex Inc | 0.00 | 0.00% |
| ---- | ||
| VRAYViewRay Inc | +0.11 | +3.82% |
Data as of 4:04pm ET, 05/20/2022
Financials
| Next reporting date | August 2, 2022 |
| EPS forecast (this quarter) | $0.24 |
| Annual revenue (last year) | $41.8M |
| Annual profit (last year) | $9.3M |
| Net profit margin | 22.30% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Winter Springs, Florida |
Forecasts
